Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma

This study was conducted to evaluate the toxicity and efficacy of pemetrexed plus dendritic cells (DCs) when administered as third-line treatment for metastatic esophageal squamous cell carcinoma (ESCC). All patients in the study group had previously failed first-line treatment with 5-fluorouracil a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bin, Li, Rui, Chang, Chun-Xiao, Han, Yong, Shi, Sheng-Bin, Tian, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935028/
https://www.ncbi.nlm.nih.gov/pubmed/27418834
http://dx.doi.org/10.2147/OTT.S107319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935028/
https://www.ncbi.nlm.nih.gov/pubmed/27418834
http://dx.doi.org/10.2147/OTT.S107319

Ejemplares similares